Literature DB >> 16572316

Scoring the effect of radiotherapy for painful bone metastases.

Sebastiano Mercadante1.   

Abstract

RATIONALE: The evaluation of the analgesic effects of radiotherapy in painful bone metastases is a matter of controversies due to a lack of appropriate tools to define the outcome. An integration of competences in monitoring the pain response and modifying the opioid treatment according to changes of the clinical condition is mandatory. PROPOSED
METHOD: A meaningful score, used in previous works to monitor the global response to an analgesic intervention in advanced cancer patients, is proposed. A case report, in which opioids are first titrated and then tapered, is described as an example of application of this method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572316     DOI: 10.1007/s00520-006-0036-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  13 in total

1.  Criteria of pain response to radiotherapy in advanced cancer patients.

Authors:  Pilar Rey; Amaya Vecino; Alvaro S Rubiales; Francisco López-Lara
Journal:  J Pain Symptom Manage       Date:  2003-03       Impact factor: 3.612

Review 2.  Radiotherapy for painful bone metastases: a systematic review.

Authors:  H J McQuay; D Carroll; R A Moore
Journal:  Clin Oncol (R Coll Radiol)       Date:  1997       Impact factor: 4.126

Review 3.  Scientific and clinical aspects of radiotherapy in the relief of bone pain.

Authors:  P J Hoskin
Journal:  Cancer Surv       Date:  1988

Review 4.  Radiotherapy for bone metastases: a critical appraisal of outcome measures.

Authors:  R Dawson; D Currow; G Stevens; G Morgan; M B Barton
Journal:  J Pain Symptom Manage       Date:  1999-03       Impact factor: 3.612

5.  Celiac plexus block versus analgesics in pancreatic cancer pain.

Authors:  Sebastiano Mercadante
Journal:  Pain       Date:  1993-02       Impact factor: 6.961

6.  Optimization of opioid therapy for preventing incident pain associated with bone metastases.

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio
Journal:  J Pain Symptom Manage       Date:  2004-11       Impact factor: 3.612

7.  Morphine-induced ventilatory failure after spinal cord compression.

Authors:  F Quevedo; D Walsh
Journal:  J Pain Symptom Manage       Date:  1999-08       Impact factor: 3.612

8.  International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases.

Authors:  Edward Chow; Jackson S Y Wu; Peter Hoskin; Lawrence R Coia; Soren M Bentzen; Peter H Blitzer
Journal:  Radiother Oncol       Date:  2002-09       Impact factor: 6.280

9.  Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion.

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio; Fabio Fulfaro
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

10.  Unexpected complication of successful nerve block. Morphine induced respiratory depression precipitated by removal of severe pain.

Authors:  G W Hanks; R G Twycross; J W Lloyd
Journal:  Anaesthesia       Date:  1981-01       Impact factor: 6.955

View more
  3 in total

Review 1.  Metastatic bone pain: treatment options with an emphasis on bisphosphonates.

Authors:  Roger von Moos; Florian Strasser; Silke Gillessen; Kathrin Zaugg
Journal:  Support Care Cancer       Date:  2008-08-06       Impact factor: 3.603

2.  STAT-ART: The Promise and Practice of a Rapid Palliative Single Session of MR-Guided Online Adaptive Radiotherapy (ART).

Authors:  Kathryn E Mittauer; Patrick M Hill; Mark W Geurts; Anna-Maria De Costa; Randall J Kimple; Michael F Bassetti; John E Bayouth
Journal:  Front Oncol       Date:  2019-10-22       Impact factor: 6.244

3.  Predictors of the Predominance of NonIndex Pain After Palliative Radiation Therapy for Painful Tumors.

Authors:  Tetsuo Saito; Ryo Toya; Etsushi Tomitaka; Tomohiko Matsuyama; Satoshi Ninomura; Takahiro Watakabe; Natsuo Oya
Journal:  Adv Radiat Oncol       Date:  2018-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.